Placebo analgesia

Last updated

Placebo analgesia occurs when the administration of placebos leads to pain relief. Because placebos by definition lack active ingredients, the effect of placebo analgesia is considered to result from the patient's belief that they are receiving an analgesic drug or other medical intervention. It has been shown that, in some cases, the endogenous opioid system is critical for mediating placebo analgesia, as evidenced by the ability of such analgesia to be reduced by the opioid antagonist naloxone. [1] [2] However, it is also possible for placebo analgesia to be mediated by non-opioid mechanisms, in which case it would not be affected by naloxone. [3] Other research has indicated that the human spinal cord, [4] prefrontal cortex, [5] and rostral anterior cingulate cortex [6] also play a role in placebo analgesia.

Contents

Psychological mechanisms

Pavlovian classical conditioning

Classical conditioning has been identified as a means by which we can induce placebo analgesia with drugs.

Recent research demonstrates how a neutral stimulus, [7] experienced with an unconditioned stimulus, can generate a conditioned response, i.e., inducing analgesic effects, after a short conditioning period. In this study, an experimental group was given cyclosporine with a drink; here, the drink acts as the neutral stimulus and cyclosporine the unconditioned stimulus. When the two are ingested concurrently, an association is learnt, generating a conditioned stimulus of drink. This results in a conditioned response of pain-relief. In this particular study, analgesia was observed during the evocation stage, where participants were exposed to the drink and a placebo, then displayed a decreased lymphocyte activity.

Classical conditioning has been identified as a means to induce analgesia without drugs also. [8] [9] Common to-be conditioned stimuli in studies investigating analgesia are various coloured lights, e.g., blue, and orange and a common unconditioned stimulus, electric shocks. During conditioning phases of experiments, one light is displayed at the same time as a shock is administered. The shock comes from electrodes secured to the hands, where the intensity alternates between two extremes, generally high and non-painful, so participants can identify the difference and therefore bridge an association between the lights and shocks given, e.g., blue = not painful, and orange = very painful.

The shocks act as unconditioned stimuli, producing unconditioned responses, i.e., pain, and the neutral stimuli are the different coloured lights. In the experimental phase, participants are exposed to the same lights, but this time the shocks are uncoordinated; orange no longer signifies a painful shock, instead a weaker, non-painful shock and blue, now signifies pain. This is where the analgesic effect occurs. Participants witnessing both lights in a randomised sequence, state that the shock administered with the blue light is less painful than that of the one with the orange. This happens because the association bridged between the lights and shock intensity, gives participants an idea of what the shocks will feel like, when a certain light is shown. Owing to this, high intensity shocks that intend to cause pain, won’t generate intense pain, because the pain level associated with that specific light is low.

Clinical applications

The applicability to pharmacotherapy is extensive. On one hand, the theory of classical conditioning suggests that medication dosage could be reduced, by associating it with another substance, like a nice tasting drink, therefore allowing people to slowly reduce and stop taking the medication, whilst maintaining the symptom-relieving effects. Theoretically, it should work, however in practice may not be feasible, as effects of conditioning last for a short period of time, approximately 4–7 days. [10] This would mean constant classical conditioning using the medication would need to be conducted, which is likely to have reservations from an ethical viewpoint. This durability can be affected by a person’s previous experience with therapy. Given a person has undergone therapy before, whether a negative or positive experience, the staggered reduction in stimuli affectivity, to induce an analgesic effect, will create an effect that is larger, prior the trial and smaller, after it. [11] This in clinical application would be inutile as therapy should not lose its efficacy over an extended period of time.

On the other hand, research on the role that both expectancy, alongside conditioning play in inducing the analgesic effect, have prompted ideas to better the practice of pharmacotherapy. Expectancy in the analgesic effect comes from the conditioning prior, where the analgesic is associated with physiological pain relief. In practice, [12] this knowledge can inform how specialists explain medicative therapy to their patients. Specialists could exercise emphasis on the symptom-relieving effect of the tablets, as opposed to the side effects. This would create an expectation in the patient’s mind, of how they should feel upon taking the medication, as well as provide them with confidence it’s going to be beneficial for them. This could be especially useful for treating those with chronic pain.

Classical conditioning can inform pharmacotherapy, in encouraging clinicians to help their patients to create associations between the analgesic medication and between pain relieving techniques. [13] By developing these techniques, even if the medication dosage were reduced, to act as a single-blind placebo, those patients would still be able to experience some pain relief. This supports the idea of using behavioural conditioning to relieve patients of their pain and not need to continue medication at the same time, despite the durability constraints.

Social observational learning

The social learning theory, as part of behaviourism, is considered a way by which analgesic effects can be induced. [14] Where a demonstrator sits with participants and responds to different coloured shocks administered when different lights appear, like above, the participants observing report the same answers as reported by the demonstrator. Separately, whilst the associations constructed around shock intensity through social observation were true based on statistical tests, the perception of the experience differ from that of the demonstrator. Alongside classical conditioning and social observational learning are verbal suggestions, tested as ways in which to engender analgesic effects. Of the three, classical conditioning and social observational learning are the most effective, regarding the strength of analgesic effects. An additional contributor to the analgesic effect, is empathy. [15] This can be measured using the Interpersonal Reactivity Index, containing subscales of which Empathetic Concern was the aspect positively correlated with social observational learning. This is suggestive of the idea that prosocial behaviour may be linked to placebo effects, as empathy scores tend to be higher where social learning ‘gains’ were greater.

The obtaining of empathy whilst learning how to respond to pain stimuli, is a stark contrast to the first-hand experience of pain, and how empathy is affected by that. Meta-analytical research [16] demonstrates shared regions between the experience of pain and empathy. The dynamics of this relatability, having been investigated, show that both functions cannot be at their most active, at the same time. [17] Instead, they are negatively correlated, when placebo analgesia is being experienced, the ability to empathise with oneself or others decreases greatly. This has implications for medication, specifically for painkillers, with possible evocation of anti-social attitudes amongst people, as was found with acetaminophen. [18]

Related Research Articles

<span class="mw-page-title-main">Fear</span> Basic emotion induced by a perceived threat

Fear is an intensely unpleasant emotion in response to perceiving or recognizing a danger or threat. Fear causes psychological changes that may produce behavioral reactions such as mounting an aggressive response or fleeing the threat. Fear in human beings may occur in response to a certain stimulus occurring in the present, or in anticipation or expectation of a future threat perceived as a risk to oneself. The fear response arises from the perception of danger leading to confrontation with or escape from/avoiding the threat, which in extreme cases of fear can be a freeze response.

<span class="mw-page-title-main">Pain</span> Type of distressing feeling

Pain is a distressing feeling often caused by intense or damaging stimuli. The International Association for the Study of Pain defines pain as "an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage."

Operant conditioning, also called instrumental conditioning, is a learning process where voluntary behaviors are modified by association with the addition of reward or aversive stimuli. The frequency or duration of the behavior may increase through reinforcement or decrease through punishment or extinction.

<span class="mw-page-title-main">Placebo</span> Substance or treatment of no therapeutic value

A placebo can be roughly defined as a sham medical treatment. Common placebos include inert tablets, inert injections, sham surgery, and other procedures.

Classical conditioning is a behavioral procedure in which a biologically potent physiological stimulus is paired with a neutral stimulus. The term classical conditioning refers to the process of an automatic, conditioned response that is paired with a specific stimulus.

A nocebo effect is said to occur when negative expectations of the patient regarding a treatment cause the treatment to have a more negative effect than it otherwise would have. For example, when a patient anticipates a side effect of a medication, they can experience that effect even if the "medication" is actually an inert substance. The complementary concept, the placebo effect, is said to occur when positive expectations improve an outcome. The nocebo effect is also said to occur in someone who falls ill owing to the erroneous belief that they were exposed to a toxin, e.g. a physical phenomenon they believe is harmful, such as EM radiation.

<span class="mw-page-title-main">Hyperalgesia</span> Abnormally increased sensitivity to pain

Hyperalgesia is an abnormally increased sensitivity to pain, which may be caused by damage to nociceptors or peripheral nerves and can cause hypersensitivity to stimulus. Prostaglandins E and F are largely responsible for sensitizing the nociceptors. Temporary increased sensitivity to pain also occurs as part of sickness behavior, the evolved response to infection.

Sensitization is a non-associative learning process in which repeated administration of a stimulus results in the progressive amplification of a response. Sensitization often is characterized by an enhancement of response to a whole class of stimuli in addition to the one that is repeated. For example, repetition of a painful stimulus may make one more responsive to a loud noise.

<span class="mw-page-title-main">Proglumide</span> Chemical compound

Proglumide (Milid) is a drug that inhibits gastrointestinal motility and reduces gastric secretions. It acts as a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. It was used mainly in the treatment of stomach ulcers, although it has now been largely replaced by newer drugs for this application.

<span class="mw-page-title-main">Pain in fish</span> Overview about the pain in fish

Fish fulfill several criteria proposed as indicating that non-human animals experience pain. These fulfilled criteria include a suitable nervous system and sensory receptors, opioid receptors and reduced responses to noxious stimuli when given analgesics and local anaesthetics, physiological changes to noxious stimuli, displaying protective motor reactions, exhibiting avoidance learning and making trade-offs between noxious stimulus avoidance and other motivational requirements.

<span class="mw-page-title-main">Pain in animals</span> Overview about pain in animals

Pain negatively affects the health and welfare of animals. "Pain" is defined by the International Association for the Study of Pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage." Only the animal experiencing the pain can know the pain's quality and intensity, and the degree of suffering. It is harder, if even possible, for an observer to know whether an emotional experience has occurred, especially if the sufferer cannot communicate. Therefore, this concept is often excluded in definitions of pain in animals, such as that provided by Zimmerman: "an aversive sensory experience caused by actual or potential injury that elicits protective motor and vegetative reactions, results in learned avoidance and may modify species-specific behaviour, including social behaviour." Nonhuman animals cannot report their feelings to language-using humans in the same manner as human communication, but observation of their behaviour provides a reasonable indication as to the extent of their pain. Just as with doctors and medics who sometimes share no common language with their patients, the indicators of pain can still be understood.

<span class="mw-page-title-main">Pain in crustaceans</span> Ethical debate

Pain in crustaceans is a scientific debate which questions whether they experience pain or not. Pain is a complex mental state, with a distinct perceptual quality but also associated with suffering, which is an emotional state. Because of this complexity, the presence of pain in an animal, or another human for that matter, cannot be determined unambiguously using observational methods, but the conclusion that animals experience pain is often inferred on the basis of likely presence of phenomenal consciousness which is deduced from comparative brain physiology as well as physical and behavioural reactions.

Pain in babies, and whether babies feel pain, has been a large subject of debate within the medical profession for centuries. Prior to the late nineteenth century it was generally considered that babies hurt more easily than adults. It was only in the last quarter of the 20th century that scientific techniques finally established babies definitely do experience pain – probably more than adults – and developed reliable means of assessing and of treating it. As recently as 1999, it was widely believed by medical professionals that babies could not feel pain until they were a year old, but today it is believed newborns and likely even fetuses beyond a certain age can experience pain.

The hot plate test is a test of the pain response in animals, similar to the tail flick test. Both hot plate and tail-flick methods are used generally for centrally acting analgesic, while peripherally acting drugs are ineffective in these tests but sensitive to acetic acid-induced writhing test.

<span class="mw-page-title-main">Pain in invertebrates</span> Contentious issue

Pain in invertebrates is a contentious issue. Although there are numerous definitions of pain, almost all involve two key components. First, nociception is required. This is the ability to detect noxious stimuli which evokes a reflex response that moves the entire animal, or the affected part of its body, away from the source of the stimulus. The concept of nociception does not necessarily imply any adverse, subjective feeling; it is a reflex action. The second component is the experience of "pain" itself, or suffering—i.e., the internal, emotional interpretation of the nociceptive experience. Pain is therefore a private, emotional experience. Pain cannot be directly measured in other animals, including other humans; responses to putatively painful stimuli can be measured, but not the experience itself. To address this problem when assessing the capacity of other species to experience pain, argument-by-analogy is used. This is based on the principle that if a non-human animal's responses to stimuli are similar to those of humans, it is likely to have had an analogous experience. It has been argued that if a pin is stuck in a chimpanzee's finger and they rapidly withdraw their hand, then argument-by-analogy implies that like humans, they felt pain. It has been questioned why the inference does not then follow that a cockroach experiences pain when it writhes after being stuck with a pin. This argument-by-analogy approach to the concept of pain in invertebrates has been followed by others.

Many experiments have been done to find out how the brain interprets stimuli and how animals develop fear responses. The emotion, fear, has been hard-wired into almost every individual, due to its vital role in the survival of the individual. Researchers have found that fear is established unconsciously and that the amygdala is involved with fear conditioning.

<span class="mw-page-title-main">Pain in amphibians</span> Ethical issue

Pain is an aversive sensation and feeling associated with actual, or potential, tissue damage. It is widely accepted by a broad spectrum of scientists and philosophers that non-human animals can perceive pain, including pain in amphibians.

<span class="mw-page-title-main">Pain in cephalopods</span> Contentious issue

Pain in cephalopods is a contentious issue. Pain is a complex mental state, with a distinct perceptual quality but also associated with suffering, which is an emotional state. Because of this complexity, the presence of pain in non-human animals, or another human for that matter, cannot be determined unambiguously using observational methods, but the conclusion that animals experience pain is often inferred on the basis of likely presence of phenomenal consciousness which is deduced from comparative brain physiology as well as physical and behavioural reactions.

An analgesic adjuvant is a medication that is typically used for indications other than pain control but provides control of pain (analgesia) in some painful diseases. This is often part of multimodal analgesia, where one of the intentions is to minimize the need for opioids.

Association in psychology refers to a mental connection between concepts, events, or mental states that usually stems from specific experiences. Associations are seen throughout several schools of thought in psychology including behaviorism, associationism, psychoanalysis, social psychology, and structuralism. The idea stems from Plato and Aristotle, especially with regard to the succession of memories, and it was carried on by philosophers such as John Locke, David Hume, David Hartley, and James Mill. It finds its place in modern psychology in such areas as memory, learning, and the study of neural pathways.

References

  1. ↑ Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C (August 2009). "Activation of the opioidergic descending pain control system underlies placebo analgesia". Neuron. 63 (4): 533–43. doi: 10.1016/j.neuron.2009.07.014 . PMID   19709634. S2CID   2828147.
  2. ↑ Levine JD, Gordon NC, Fields HL (September 1978). "The mechanism of placebo analgesia". Lancet. 2 (8091): 654–7. doi:10.1016/S0140-6736(78)92762-9. PMID   80579. S2CID   45403755.
  3. ↑ Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (November 2005). "Neurobiological mechanisms of the placebo effect". The Journal of Neuroscience. 25 (45): 10390–402. doi:10.1523/JNEUROSCI.3458-05.2005. PMC   6725834 . PMID   16280578.
  4. ↑ Eippert F, Finsterbusch J, Bingel U, Büchel C (October 2009). "Direct evidence for spinal cord involvement in placebo analgesia". Science. 326 (5951): 404. Bibcode:2009Sci...326..404E. doi:10.1126/science.1180142. hdl: 11858/00-001M-0000-002E-89B9-7 . PMID   19833962. S2CID   206522822.
  5. ↑ Krummenacher P, Candia V, Folkers G, Schedlowski M, Schönbächler G (March 2010). "Prefrontal cortex modulates placebo analgesia". Pain. 148 (3): 368–74. doi:10.1016/j.pain.2009.09.033. PMID   19875233. S2CID   41113917.
  6. ↑ Petrovic P, Kalso E, Petersson KM, Ingvar M (March 2002). "Placebo and opioid analgesia-- imaging a shared neuronal network". Science. 295 (5560): 1737–40. Bibcode:2002Sci...295.1737P. doi:10.1126/science.1067176. hdl: 11858/00-001M-0000-0013-2552-D . PMID   11834781. S2CID   45262927.
  7. ↑ Ober K, Benson S, Vogelsang M, Bylica A, Günther D, Witzke O, Kribben A, Engler H, Schedlowski M (2012). "Plasma Noradrenaline and State Anxiety Levels Predict Placebo Response in Learned Immunosuppression". Clinical Pharmacology & Therapeutics. 91 (2): 220–226. doi:10.1038/clpt.2011.214. PMID   22166852. S2CID   33276729.
  8. ↑ Bąbel P, Bajcar EA, Adamczyk W, Kicman P, Lisińska N, Świder K, Colloca L (2017). "Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia". PLOS ONE. 12 (7): e0181856. Bibcode:2017PLoSO..1281856B. doi: 10.1371/journal.pone.0181856 . PMC   5531508 . PMID   28750001.
  9. ↑ Bąbel P, Adamczyk W, Świder K, Bajcar EA, Kicman P, Lisińska N (2017). "How Classical Conditioning Shapes Placebo Analgesia: Hidden versus Open Conditioning". Pain Medicine. 19 (6): 1156–1169. doi: 10.1093/pm/pnx177 . PMID   29016984.
  10. ↑ Colloca L, Benedetti F (2006). "How prior experience shapes placebo analgesia". Pain. 124 (1): 126–133. doi:10.1016/j.pain.2006.04.005. PMID   16701952. S2CID   25241284.
  11. ↑ Klinger R, Colloca L, Bingel U, Flor H (2014). "Placebo analgesia: Clinical applications". Pain. 155 (6): 1055–1058. doi:10.1016/j.pain.2013.12.007. PMC   4011974 . PMID   24333780.
  12. ↑ Lückemann L, Unteroberdörster M, Kirchog J, Schedlowski M, Hadamitzky M (July 2017). "Applications and limitations of behaviourally conditioned immunopharmacological responses". Neurobiology of Learning and Memory. 142 (Pt A): 91–98. doi:10.1016/j.nlm.2017.02.012. PMID   28216206. S2CID   4393564.
  13. ↑ Lückemann L, Unteroberdörster M, Kirchog J, Schedlowski M, Hadamitzky M (July 2017). "Applications and limitations of behaviourally conditioned immunopharmacological responses". Neurobiology of Learning and Memory. 142 (Pt A): 91–98. doi:10.1016/j.nlm.2017.02.012. PMID   28216206. S2CID   4393564.
  14. ↑ Colloca L, Benedetti F (2009). "Placebo analgesia induced by social observational learning". Pain. 144 (1): 28–34. doi:10.1016/j.pain.2009.01.033. PMID   19278785. S2CID   3195234.
  15. ↑ Colloca L, Benedetti F (2009). "Placebo analgesia induced by social observational learning". Pain. 144 (1): 28–34. doi:10.1016/j.pain.2009.01.033. PMID   19278785. S2CID   3195234.
  16. ↑ Lamm C, Decety J, Singer T (1 February 2011). "Meta-analytic evidence for common and distinct neural networks associated with directly experienced pain and empathy for pain". NeuroImage. 54 (3): 2492–2502. doi:10.1016/j.pain.2009.01.033. PMID   19278785. S2CID   3195234.
  17. ↑ Rütgen M, Seidel EM, Riečanský I, Lamm C (June 10, 2015). "Reduction of Empathy for Pain by Placebo Analgesia Suggests Functional Equivalence of Empathy and First-Hand Emotion Experience". The Journal of Neuroscience. 35 (23): 8938–8947. doi: 10.1523/jneurosci.3936-14.2015 . PMC   6605205 . PMID   26063925.
  18. ↑ Mischkowski D, Crocker J, Way BM (2019). "A Social Analgesic Acetaminophen (Paracetamol) Reduces Positive Empathy". Frontiers in Psychology. 10 (3): 538. doi: 10.3389/fpsyg.2019.00538 . PMC   6455058 . PMID   31001155.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.